LAUSR

Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis

Sign Up to like & get
recommendations!
1 Published in 2021 at "Drugs"

DOI: 10.1007/s40265-021-01650-7

Abstract: Ofatumumab (Kesimpta ® ) is a fully human anti-CD20 monoclonal antibody that can be self-administered by patients and is approved in several countries worldwide for the treatment of relapsing forms of multiple sclerosis (MS). In… read more here.

Keywords: generally manageable; relapsing forms; forms multiple; treatment ... See more keywords